| 000 | 01406 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515122709.0 | ||
| 264 | 0 | _c20080710 | |
| 008 | 200807s 0 0 eng d | ||
| 022 | _a1744-7666 | ||
| 024 | 7 |
_a10.1517/14656566.9.9.1519 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHashimoto, Takashi | |
| 245 | 0 | 0 |
_aTreatment strategies for pemphigus vulgaris in Japan. _h[electronic resource] |
| 260 |
_bExpert opinion on pharmacotherapy _cJun 2008 |
||
| 300 |
_a1519-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntigens, CD20 _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xadministration & dosage |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aJapan |
| 650 | 0 | 4 |
_aPemphigus _xdrug therapy |
| 650 | 0 | 4 | _aPlasmapheresis |
| 650 | 0 | 4 |
_aPrednisolone _xadministration & dosage |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tExpert opinion on pharmacotherapy _gvol. 9 _gno. 9 _gp. 1519-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14656566.9.9.1519 _zAvailable from publisher's website |
| 999 |
_c18011705 _d18011705 |
||